Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ancherythroculter nigrocauda

ABSTRACT: Ancherythroculter nigrocauda Genome sequencing and assembly

PROVIDER: PRJNA533477 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR8929630_subreads.fastq.gz	Fastqsanger.gz
	SRR8929631_subreads.fastq.gz	Fastqsanger.gz
	SRR8929633_1.fastq.gz	Fastqsanger.gz
	SRR8929633_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Ancherythroculter nigrocauda

Project description:Ancherythroculter nigrocauda Genome sequencing and assembly

| PRJNA448477 | ENA

Ancherythroculter nigrocauda

Project description:Ancherythroculter nigrocauda overview

| PRJNA207896 | ENA

Ancherythroculter nigrocauda isolate:NO9-14

Project description:Ancherythroculter nigrocauda PacBio WGS

| PRJNA493864 | ENA

Project description:DNA methylation difference in the liver of Ancherythroculter nigrocauda

| PRJNA890278 | ENA

Project description:rna-seq for Ancherythroculter nigrocauda heart and brain tissues under hypoxia stress

| PRJNA1027844 | ENA

Project description:rna-seq for liver and brain tissue of female and male Ancherythroculter nigrocauda

| PRJNA762193 | ENA

Project description:Transcriptome analysis of saline-alkali stress on the hybrid (Erythroculter ilishaeformis and Ancherythroculter nigrocauda)

| PRJNA1097380 | ENA

Project description:Effects of exercise on intestinal flora of the hybrid (Megalobrama amblycephala and Ancherythroculter nigrocauda)

| PRJNA836948 | ENA

Project description:Effects of exercise on muscle transcriptome of the hybrid (Erythroculter ilishaeformis and Ancherythroculter nigrocauda)

| PRJNA843454 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data